Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

724610.pdf (875.04 KB)

Document type

Article

Version

Published version

Publication date

2022-08-26

Publication license

cc-by (c) Rey Reñones, Cristina et al., 2022
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/190002

Type 2 diabetes mellitus and COVID-19: a narrative review

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

Abstract

Type-2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The incidence and prevalence of patients with T2DM are increasing worldwide, even reaching epidemic values in most high- and middle-income countries. T2DM could be a risk factor of developing complications in other diseases. Indeed, some studies suggest a bidirectional interaction between T2DM and COVID-19. A growing body of evidence shows that COVID-19 prognosis in individuals with T2DM is worse compared with those without. Moreover, various studies have reported the emergence of newly diagnosed patients with T2DM after SARS-CoV-2 infection. The most common treatments for T2DM may influence SARS-CoV-2 and their implication in infection is briefly discussed in this review. A better understanding of the link between TD2M and COVID-19 could proactively identify risk factors and, as a result, develop strategies to improve the prognosis for these patients.

Subject

Diabetis, COVID-19, Epidemiologia

Subject (English)

Diabetes, COVID-19, Epidemiology

Citation

Collections

Articles publicats en revistes (Medicina)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citation

REY REÑONES, Cristina, et al. Type 2 diabetes mellitus and COVID-19: a narrative review. Biomedicines. 2022. Vol. 10, num. 2089. ISSN 2227-9059. [consulted: 11 of August of 2026]. Available at: https://hdl.handle.net/2445/190002

Export metadata

JSON - METS

Share record